The prevalence of factor V 1691G-A mutation in Van region of Turkey.
نویسندگان
چکیده
The prevalence of hereditary thrombotic risk factors shows marked ethnic and geographic variations. Hereditary disorders predisposing for thrombosis are not only antithrombin, protein C and protein S deficiencies, but also hereditary defects such as factor V 1691 G-A (Leiden) (FVL) and prothrombin 20210 G-A mutations [1,2]. FVL causes activated protein C resistance and is the most common thrombophilic mutation worldwide [3]. Guanine to adenine change leads to a replacement of glutamine with arginine at amino acid position 506. It is most prevalent among Caucasians but not found in the Japanese and Africans [1-3]. FVL frequency in the Turkish population has been reported from different parts of Turkey. Overall frequency was reported to be 8% [4]. FVL is believed to have originated somewhere close to Anatolia approximately 20,000 years ago, and the existence of mutation in this geography is expected to be high [5]. Urartu, one of the ancient civilizations in Anatolia, was an Iron Age kingdom, centered on Van Lake in Eastern Turkey. In the study of Dogan Alakoc et al. [5], 60 teeth from the excavations of Van Yoncatepe fortress were subjected to DNA analysis. Of the total 60 samples, one male sample demonstrated a positive amplification result for FV gene and was found to be heterozygous for FVL. As there is no report on the prevalence of FVL in the population in the Van region of Turkey, we aimed to determine the prevalence in that province. A total of 100 healthy children were studied. The mean age of the 100 subjects was 9.08±5.94 years, and 49 (49%) were males and 51 (51%) females. A written consent was obtained from their parents. The frequency of FVL was determined as 9%. FVL frequency is about 3% to 10% in Europeans, but the FVL mutation is rare in East and/or Southeast Asian populations; however, it has been determined at high frequencies in Azerbaijan and Kyrgyzstan populations [6-9]. Wide variations in the frequency of FVL have been reported in different surveys carried out in many countries, depending on the geographical location and the ethnic background of the population. In Caucasian populations, the carrier frequency of FVL was reported to be 2–15% [4]. The highest prevalence rates were obtained in Mediterranean countries [3-7]. The rates from different regions of Turkey and our results showed similar frequencies. The high prevalence of the mutation in the Middle East leads to the possibility that the founders …
منابع مشابه
جهش ژنتیکی 1691G>A ژن فاکتور 5 انعقادی در جمعیت سالم استان آذربایجان شرقی
Background & Aims: Genetic mutation, 1691G> A common polymorphism in a gene that is inherited coagulation Factor 5 is associated with increased risk of thrombosis. This mutation in different populations can develop in the prognosis of thrombotic disorders, cardiovascular disorders recurrent miscarriage and other thrombotic factors are useful. Study using appropriate strategies such as review o...
متن کاملموتاسیون ژن فاکتور V لیدن در بیماران مبتلا به سندرم بهجت و ارتباط آن با علایم بالینی
Background: Behcet’s disease (BD) is a multisystemic inflammatory disease with unknown origin characterized by recurrent oral aphtous ulcers, genital, ocular and skin lesions. A single point mutation 1691G to A in the factor V gene increases the risk of venous thrombosis. This study designed to determine factor V Leiden mutation in Behcet’s disease, and to find out it's relationship with the cl...
متن کاملPrevalence of 1691G>A FV mutation in females from Bosnia and Herzegovina--a preliminary report.
Factor V is the liver-synthesized multidomain glycoprotein encoded by a gene localised on chromosome 1q23. The point mutation 1691G>A in this gene results in formation of an altered protein of V Factor resistant to activated protein C (APC) cleavage. This mutation alone is the most frequent cause of inborn thrombophilia and the most widely acknowledged genetic risk factor for venous thrombosis ...
متن کاملFactor V Leiden is not common in patients diagnosed with primary pulmonary hypertension.
Substantial evidence suggests that thrombosis contributes to the pathogenesis of primary pulmonary hypertension (PPH). An abnormal factor V (factor V Leiden) may contribute to thrombosis in the pulmonary microcirculation of PPH patients. A point mutation in which adenine is substituted for guanine at nucleotide 1691 (1691A) alters factor V so that it resists cleavage by activated protein C. Het...
متن کاملFactor V Leiden, MTHFR C677T and Prothrombin Gene Mutation G20210A in Iranian Patients with Venous Thrombosis
Background: Factor V Leiden, Prothrombin gene (G20210A) and MTHFR (C677T) polymorphism are the main biomarkers for evaluation of tendency for venous thromboembolism. We aimed to investigate the frequency of mutations in factor V Leiden, Prothrombin G20210A and MTHFR C677T and identify the genetic status for these mutations in patients with venous thrombosis. Methods: This study was carried out...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Turkish journal of haematology : official journal of Turkish Society of Haematology
دوره 27 3 شماره
صفحات -
تاریخ انتشار 2010